Avalo Therapeutics, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 1 28 18 7 7 5 18 2 0
Przychód Δ r/r 0.0% -100.0% 0.0% 0.0% inf% 2312.2% -34.1% -63.2% -0.8% -19.4% 234.4% -89.3% -77.1%
Marża brutto -10142.4% 0.0% 0.0% 0.0% 100.0% 97.7% 59.2% -72.3% 95.5% 72.4% 81.0% 33.3% -6084.8%
EBIT (mln) -10 -13 -17 -11 -16 14 -39 -17 -27 -82 -37 -23 -69
EBIT Δ r/r 0.0% 23.3% 32.3% -35.7% 46.0% -186.4% -383.0% -55.8% 55.0% 204.7% -54.4% -37.4% 192.2%
EBIT (%) -12676.4% 0.0% 0.0% 0.0% -1394.6% 49.9% -214.5% -257.7% -402.3% -1521.6% -207.4% -1218.5% -15535.6%
Koszty finansowe (mln) 0 0 -1 -1 0 0 -1 0 0 -2 4 3 3
EBITDA (mln) -10 -13 -19 -12 -16 14 7 -17 -25 -81 -37 -23 -69
EBITDA(%) -12658.2% 0.0% 0.0% 0.0% -1401.0% 51.6% 35.5% -257.2% -376.4% -1492.9% -207.3% -1210.3% -15535.6%
Podatek (mln) 0 0 -1 -1 0 2 -0 0 -3 -0 0 0 0
Zysk Netto (mln) -10 -13 -16 -10 -16 12 -40 -16 -64 -84 -42 -32 -35
Zysk netto Δ r/r 0.0% 24.4% 23.1% -34.7% 57.0% -172.1% -437.4% -59.4% 295.7% 31.0% -50.6% -24.3% 11.4%
Zysk netto (%) -12674.7% 0.0% 0.0% 0.0% -1428.5% 42.7% -218.5% -241.1% -961.1% -1562.6% -230.8% -1639.5% -7965.8%
EPS -199.77 -33.81 -41.61 -56.55 -22.38 5.04 -13.82 -1092.89 -2780.57 -2432.0 -1062.68 -113.58 -4.32
EPS (rozwodnione) -199.77 -33.81 -41.61 -56.55 -22.38 5.04 -13.82 -1092.89 -2780.57 -2432.0 -1062.68 -113.58 -3.26
Ilośc akcji (mln) 0 0 0 0 1 2 3 0 0 0 0 0 8
Ważona ilośc akcji (mln) 0 0 0 0 1 2 3 0 0 0 0 0 11
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD